Literature DB >> 8841697

Prognosis and treatment of sudden sensorineural hearing loss.

B L Fetterman1, J E Saunders, W M Luxford.   

Abstract

Most cases of sudden sensorineural hearing loss (SHL) are idiopathic. Consequently, the otologist may be asked to predict hearing recovery and select a treatment strategy without fully understanding the disease process. We retrospectively reviewed the charts of 837 patients with SHL to evaluate the prognostic value of specific clinical parameters and the effectiveness of steroid and vasodilator treatments. Treatment response was defined by the patient's subjective response and audiological criteria. Patients who were treated with steroids and/or vasodilators were more likely to improve. Patients who improved had a worse initial pure-tone average (PTA) than those who did not improve. In addition, those with poorer initial speech discrimination scores, worse initial thresholds at 4,000 Hz, younger age, and greater number of treatments were more likely to improve. Neither the electronystagmogram results nor the initial audiogram shape were valuable indicators. Recognition of prognostic indicators can help in counselling patients and in the evaluation of treatment response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841697

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  51 in total

1.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

2.  How long should the sudden hearing loss patients be followed after early steroid combination therapy?

Authors:  In Seok Moon; Jin Kim; So-Yoon Lee; Hyun Seung Choi; Won-Sang Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

Review 3.  Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis.

Authors:  Maggie Kuhn; Selena E Heman-Ackah; Jamil A Shaikh; Pamela C Roehm
Journal:  Trends Amplif       Date:  2011-05-22

4.  SCORE risk scale as a prognostic factor after sudden sensorineural hearing loss.

Authors:  Ana Sousa Menezes; Daniela Ribeiro; António Lima; Daniel Miranda; Joana Guimarães; Luís Dias
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-20       Impact factor: 2.503

5.  Sudden sensorineural hearing loss.

Authors:  Christopher Joseph Chin; Kathryn Dorman
Journal:  CMAJ       Date:  2017-03-20       Impact factor: 8.262

6.  Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.

Authors:  Arne Liebau; Olivia Pogorzelski; Alec N Salt; Stefan K Plontke
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

7.  Increased levels of mean platelet volume: a possible relationship with idiopathic sudden hearing loss.

Authors:  Sahin Ulu; M Sena Ulu; Ahmet Ahsen; Fatih Yucedag; Abdullah Aycicek; Sefa Celik
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-23       Impact factor: 2.503

8.  Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss.

Authors:  Yao-wen Wang; Ji-hao Ren; Yong-de Lu; Tuan-fang Yin; Ding-hua Xie
Journal:  J Zhejiang Univ Sci B       Date:  2012-03       Impact factor: 3.066

9.  Long-term Audiometric Outcomes in Unilateral Sudden Sensorineural Hearing Loss without Recurrence.

Authors:  Giancarlo Pecorari; Giuseppe Riva; Nertila Naqe; Gabriele Bruno; Matteo Nardo; Roberto Albera
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

Review 10.  Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.

Authors:  Tomás Labatut; María José Daza; Antonio Alonso
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.